Preclinical Antitumor Activity and Pharmacokinetics of Methyl-2-Benzimidazolecarbamate (FB642)
暂无分享,去创建一个
D. V. Von Hoff | G. Mangold | D. Dexter | D. Hao | J. Marty | S. Weitman | J. Rizzo | S. Stringer | Rodney V. Moore | J. B. Camden | Stephanie Stringer
[1] D. V. Von Hoff,et al. Exploring the mechanisms of action of FB642 at the cellular level , 2001, Journal of Cancer Research and Clinical Oncology.
[2] D. V. Von Hoff,et al. The new dioxolane, (-)-2'-deoxy-3'-oxacytidine (BCH-4556, troxacitabine), has activity against pancreatic human tumor xenografts. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[3] D. V. Von Hoff,et al. Preclinical antitumor activity of 6-hydroxymethylacylfulvene, a semisynthetic derivative of the mushroom toxin illudin S. , 1997, Cancer research.
[4] R. Tishler,et al. Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. , 1995, Cancer research.
[5] A. Mirčić,et al. Apoptosis induced by microtubule disrupting drugs in normal murine thymocytes in vitro. , 1995, Scanning microscopy.
[6] M. Nakai,et al. Morphological changes in the rat Sertoli cell induced by the microtubule poison carbendazim. , 1994, Tissue & cell.
[7] B. Klosowska,et al. The fate of 14C-carbendazim in rat. , 1986, Xenobiotica; the fate of foreign compounds in biological systems.
[8] E. Lacey,et al. Structure-activity relationships of benzimidazole carbamates as inhibitors of mammalian tubulin, in vitro. , 1985, Biochemical pharmacology.
[9] M. Roberts,et al. The pharmacokinetics and bioavailability of a tracer dose of [3H]-mebendazole in man. , 1985, British journal of clinical pharmacology.
[10] J. F. Ryley,et al. Mode of action of antifungal agents , 1984 .
[11] K. Gull,et al. The interaction of benzimidazole carbamates with mammalian microtobule protein. , 1979, Biochemical pharmacology.
[12] N. Morris,et al. Identification of a gene for β-tubulin in aspergillus nidulans , 1978, Cell.
[13] L. C. Davidse,et al. Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this agent in mutant strains of A. nidulans , 1977 .
[14] E. Lyons,et al. METHYL 5(6)-PHENYLSULFINYL-2-BENZIMIDAZOLECARBAMATE, A NEW, POTENT ANTHELMINTIC , 1976 .
[15] M. De Brabander,et al. A new culture model facilitating rapid quantitative testing of mitotic spindle inhibition in mammalian cells. , 1976, Journal of the National Cancer Institute.
[16] G. Atassi,et al. R17934-NSC 238159: a new antitumor drug--I. Effect on experimental tumors and factors influencing effectiveness. , 1975, European journal of cancer.
[17] G. Atassi,et al. R17934-NSC238159: a new antitumor drug--II. Effect on mitotic cycle of L1210 leukemia cells in vivo and synergism with cytosine arabinoside (NSC63878). , 1975, European journal of cancer.